Industrial Bread Composition: Potential Implications for Patients with Inflammatory Bowel Disease
- PMID: 40647225
- PMCID: PMC12252189
- DOI: 10.3390/nu17132120
Industrial Bread Composition: Potential Implications for Patients with Inflammatory Bowel Disease
Abstract
Background: Ultra-processed food (UPF) intake, particularly that of industrial breads rich in food additives (FAs) like emulsifiers, has been linked to higher risk of inflammatory bowel diseases (IBD). Here, we screened the ingredients and FAs used in the bread industry and reviewed their potential biological effects. Methods: We consecutively screened breads available at supermarket and health food store chains in Israel. Bread products were analyzed by dietitians and categorized into three categories based on their composition: low processed (traditional ingredients), medium processed (additives like malt and fibers), and highly processed (FAs like emulsifiers and preservatives). We conducted a literature review to explore the links between the identified FAs, microbial composition and intestinal inflammation. Results: Of the 233 breads screened, 195 (84%) were highly processed, 9 (4%) medium-processed and 29 (12%) low-processed. We identified 37 different FAs and ingredients used. Most breads contained preservatives-189 (81%), and emulsifiers-178 (76%). Calcium propionate (E-282) was the most prevalent preservative present in 112 (48%) breads, while sodium-stearoyl-2-lactylate (SSL-E-481) was the most prevalent emulsifier present in 86 (37%) breads. The literature review revealed that 19 (51%) FAs used in the bread industry were associated with the exacerbation of inflammation or gut microbiome dysbiosis by increasing cytokine production and adversely affecting microbial composition. Conclusions: Most of the available breads in Israel are highly processed, containing FAs that may mediate intestinal inflammation. Low-processed breads are available and may be more recommended to patients with IBD. Further understanding of the role of FAs in IBD etiology may guide dietary recommendations.
Keywords: emulsifiers; food additives (FAs); inflammatory bowel disease (IBD); microbiome; preservatives; ultra-processed foods (UPFs).
Conflict of interest statement
These authors disclose the following: Lihi Godny: Takeda, Ferring, Altman; Tamar Pfeffer-Gik: Janssen, Danone, Altman; Henit Yanai: Pfizer, Abbvie, Janssen, Takeda, Bristol Myers Squibb, Eli-Lilly; Iris Dotan: Abbvie, Arena, Gilead/Galapagos, Genentech/Roche, Athos, Janssen, Pfizer, Takeda, Altman research, Celgene/BMS, Celltrion, Eli-Lilly, Dr. Falk Pharma, Ferring, Sandoz, and Harp diagnostics. The remaining authors disclose no conflicts.
Figures


Similar articles
-
Definitions of ultra-processed foods beyond NOVA: a systematic review and evaluation.Food Nutr Res. 2025 Jun 16;69. doi: 10.29219/fnr.v69.12217. eCollection 2025. Food Nutr Res. 2025. PMID: 40655201 Free PMC article. Review.
-
Should Grain-Based Staple Foods Be Included in Admonitions to "Avoid Processed and Ultra-Processed Food"?Nutrients. 2025 Jun 30;17(13):2188. doi: 10.3390/nu17132188. Nutrients. 2025. PMID: 40647292 Free PMC article. Review.
-
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.J Parkinsons Dis. 2025 Jun;15(4):766-779. doi: 10.1177/1877718X251328567. Epub 2025 May 7. J Parkinsons Dis. 2025. PMID: 40336252
-
Ultra-processed foods, allergy outcomes and underlying mechanisms in children: An EAACI task force report.Pediatr Allergy Immunol. 2024 Sep;35(9):e14231. doi: 10.1111/pai.14231. Pediatr Allergy Immunol. 2024. PMID: 39254357
-
Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging Evidence.Nutrients. 2025 Aug 19;17(16):2677. doi: 10.3390/nu17162677. Nutrients. 2025. PMID: 40871705 Free PMC article. Review.
References
-
- Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
-
- Wang R., Li Z., Liu S., Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: A systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13:e065186. doi: 10.1136/bmjopen-2022-065186. - DOI - PMC - PubMed
-
- Alatab S., Sepanlou S.G., Ikuta K., Vahedi H., Bisignano C., Safiri S., Sadeghi A., Nixon M.R., Abdoli A., Abolhassani H., et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020;5:17–30. doi: 10.1016/S2468-1253(19)30333-4. - DOI - PMC - PubMed
-
- Narula N., Wong E.C.L., Dehghan M., Mente A., Rangarajan S., Lanas F., Lopez-Jaramillo P., Rohatgi P., Lakshmi P.V.M., Varma R.P., et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: Prospective cohort study. BMJ. 2021;374:n1554. doi: 10.1136/bmj.n1554. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous